Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

The study is evaluating AJ1-11095, a novel agent for the treatment of myelofibrosis that did not respond to or relapsed ...

- Late-Breaker Poster Presentation to occur at the 39 th Annual Society for Immunotherapy of Cancer (SITC) conference on November 9 th, 2024 - - Ongoing study to evaluate OR502 as monotherapy and ...

“Our team is excited to initiate this important clinical trial to assess the ... also follows the recent initiation of our Phase 1 trial of ZW171, marking an additional important step forward ...

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors Back to video VANCOUVER, British Columbia, Nov. 05, 2024 (GLOBE ...

The primary objective of this Phase 1 randomized, double-blind, placebo-controlled, multi-part single and multiple ascending dose clinical study is to evaluate the safety, tolerability and ...

KVA12123 was well tolerated with no dose limiting toxicities (DLT) and a favorable safety profile at all dose levels in both arms of the study. The poster presentation (SITC #625): “A phase 1/2 ...

Phase 1 studies for ZW171 and ZW191 are now actively ... Zymeworks’ clinical development of its product candidates and enrollment in its clinical trials; the potential addressable market of ...

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell lung cancers VANCOUVER, British ...